Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
China Journal of Chinese Materia Medica ; (24): 1632-1637, 2008.
Artículo en Chino | WPRIM | ID: wpr-264880

RESUMEN

To investigate the historical origins of folk herbal medicine 'Xuelihua', the origin of 'Xuelihua' was confirmed by textural, botanical characteristics research, investigation of therapeutic effects and field survey. The 'Xuelihua' which was originally recorded in 'Bencao Gangmu Shiyi' (A Supplement to the Compendium of Materia Medica) should be 'Riben Shegencao' (Ophirrhiza japonica) of Rubiaceae family.


Asunto(s)
China , Medicamentos Herbarios Chinos , Clasificación , Farmacología , Usos Terapéuticos , Materia Medica , Medicina Tradicional China , Rubiaceae , Clasificación
2.
Journal of Zhejiang University. Science. B ; (12): 125-131, 2005.
Artículo en Inglés | WPRIM | ID: wpr-316364

RESUMEN

Epigallocatechin-3-gallate (EGCG) has shown remarkably anti-cancer activity, with its bioactivity being related to reactive conditions, such as pH and metal ions. The present study investigated the degradation of EGCG and its effect on prostate cancer cell in the presence of Cu2+. EGCG was incubated with prostate cancer cells, LNCaP, pretreated with or without Cu2+. EGCG in F-12 medium was quantified using HPLC and the viability of cells was assessed by gel electrophoresis, flow cytometry, and electron microscope. The results of HPLC showed that EGCG degraded completely within 12 h in F-12 medium with or without Cu2+. Gel electrophoresis and flow cytometry did not detect apoptosis of LNCaP cells when they were incubated with EGCG. Electron microscopy examination revealed that EGCG-Cu2+ complex led to damage of cytoplasm membrane in LNCaP cells. It was speculated that not EGCG, but its oxide and complex with Cu2+, are the bioactive components responsible for its cytotoxicity to LNCaP prostate cancer cells.


Asunto(s)
Humanos , Masculino , Anticarcinógenos , Apoptosis , Catequina , Línea Celular Tumoral , Proliferación Celular , Supervivencia Celular , Cobre , Metabolismo , Relación Dosis-Respuesta a Droga , Combinación de Medicamentos , Neoplasias de la Próstata , Quimioterapia , Patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA